N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143476 |
| CAS No | NA |
| Mol.F. | C25H38N4O9 |
| Mol.Wt. | 538.60 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143477 |
| CAS No | NA |
| Mol.F. | C7H14N4O3 |
| Mol.Wt. | 202.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143478 |
| CAS No | NA |
| Mol.F. | C25H36N4O9 |
| Mol.Wt. | 536.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143479 |
| CAS No | NA |
| Mol.F. | C20H30N4O7 |
| Mol.Wt. | 438.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143480 |
| CAS No | NA |
| Mol.F. | C21H34N4O7S |
| Mol.Wt. | 486.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143481 |
| CAS No | NA |
| Mol.F. | C10H10N2O6 |
| Mol.Wt. | 254.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143482 |
| CAS No | NA |
| Mol.F. | C12H14N2O6 |
| Mol.Wt. | 282.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143483 |
| CAS No | NA |
| Mol.F. | C25H29N3O8 |
| Mol.Wt. | 499.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143484 |
| CAS No | NA |
| Mol.F. | C27H39N3O8 |
| Mol.Wt. | 533.62 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143485 |
| CAS No | NA |
| Mol.F. | C15H20N2O5 |
| Mol.Wt. | 308.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143486 |
| CAS No | NA |
| Mol.F. | C26H31N3O8 |
| Mol.Wt. | 513.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143487 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.29 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143488 |
| CAS No | NA |
| Mol.F. | C16H26N2O3 |
| Mol.Wt. | 294.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143489 |
| CAS No | NA |
| Mol.F. | C9H12N4O2S |
| Mol.Wt. | 240.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143490 |
| CAS No | NA |
| Mol.F. | C13H20N4O2S |
| Mol.Wt. | 296.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143491 |
| CAS No | NA |
| Mol.F. | C14H17N5O |
| Mol.Wt. | 271.3 g/mole |
| INV STATUS | In Stock |